Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : OPT101
Therapeutic Area : Nephrology
Study Phase : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Opterion Health Seeks Approval for First-in-Human OPT101 Study in Advanced CKD
Details : OPT101 is a novel non-glucose-based osmotic agent bringing much-needed new therapy options to patients with renal failure.
Product Name : OPT101
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 17, 2025
Lead Product(s) : OPT101
Therapeutic Area : Nephrology
Highest Development Status : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable